Panacea Biotec Ltd operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Panacea Biotec Ltd with three other
pharmaceutical manufacturers in Asia:
Hester Pharmaceuticals Limited
sales of 1.78 billion Indian Rupees [US$24.82 million]
of which 73%
was Poultry Vaccines),
(2.96 billion Japanese Yen [US$27.22 million]
Pharma Foods International Co.Ltd
based in Japan
(10.53 billion Japanese Yen [US$97.01 million]
of which 81%
was Functional product(Online business)).
Panacea Biotec Ltd reported sales of 4.51 billion Indian Rupees (US$62.80 million)
March of 2019.
decrease of 23.1%
versus 2018, when the company's sales were 5.86 billion Indian Rupees.
Contributing to the drop in overall sales was the 99.9% decline
in Research and Development, from 97.98 million Indian Rupees to 120,000.00 Indian Rupees.
There were also decreases in sales in
Formulation (down 11.1% to 3.60 billion Indian Rupees)
Vaccine (down 48.6% to 961.89 million Indian Rupees)